# US 2019/0376113 A1 · Activity sensor with tunable analyte

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0376113 A1
- Document ID: US20190376113A1
- Status: Published application
- Kind: A1
- Application number: 16/355,178
- Filed: 2019-03-15
- Published: 2019-12-12
- Earliest claimed: 2018-06-08
- Assignees: Glympse Bio, Inc.
- Applicants: Glympse Bio, Inc.
- Inventors: Sangeeta Bhatia; Gabriel Kwong; Eric Huang; Sirshendu Roopom Banerjee; Andrew Warren; Sophie Cazanave
- Web page: https://patentgrep.com/patent/US20190376113A1

## CPC

- C07K 14/00: Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K 47/10: Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A61K 47/60: the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
- A61K 47/65: Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
- A61P 31/00: Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- C07K 1/12: by hydrolysis {, i.e. solvolysis in general}
- C07K 11/02: cyclic, e.g. valinomycins {; Derivatives thereof}
- C12Q 1/37: involving peptidase or proteinase
- G01N 33/54306: {Solid-phase reaction mechanisms}
- G01N 33/54313: {the carrier being characterised by its particulate form}
- G01N 33/54393: {Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding}
- G01N 33/68: involving proteins, peptides or amino acids {(involving lipoproteins G01N33/92)}
- A61K 38/00: Medicinal preparations containing peptides (peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00)
- G01N 2333/96494: Matrix metalloproteases, e. g. 3.4.24.7
- G01N 2800/085: Liver diseases, e.g. portal hypertension, fibrosis, cirrhosis, bilirubin
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

A nanoparticle activity sensor containing a reporter and at least one tuning domain that modifies a distribution or residence time of the activity sensor when administered to a patient. When administered to the patient, the activity sensor enters cells or tissue where it is cleaved by enzymes specific to a physiological state such as a disease to release a detectable analyte. The tuning domains include molecular structures that modulate distribution or decay by protecting the particle from premature cleavage and indiscriminate hydrolysis, shielding the particle from immune detection and clearance, or by targeting the particle to specific tissue, bodily fluids, or cell types.

## Claims

### Claim 1

An activity sensor comprising:
a carrier comprising one or a plurality of molecular subunits; and
a plurality of detectable reporters, each linked to the carrier by a cleavable linker containing the cleavage site of an enzyme, wherein the activity sensor reports activity of one or more enzymes by releasing the reporters upon cleavage by the one or more enzymes.

### Claim 2 (depends on 1)

The activity sensor of claim 1, wherein carrier comprises a poly ethylene glycol (PEG) scaffold of covalently linked PEG subunits.

### Claim 3 (depends on 1)

The activity sensor of claim 1, wherein at least four detectable reporters are linked via cleavage sites to report activity of at least four different enzymes.

### Claim 4 (depends on 1)

The activity sensor of claim 1, wherein each detectable reporter and cleavable linker comprises a polypeptide susceptible to cleavage by a protease.

### Claim 5 (depends on 1)

The activity sensor of claim 1, further comprising a tuning domain that modifies a distribution or residence time of the activity sensor within a subject when administered to the subject.

### Claim 6 (depends on 5)

The activity sensor of claim 5, wherein the carrier comprises a multi-arm PEG scaffold and the detectable reporters and cleavable linkers each comprise a polypeptide linked to the PEG scaffold.

### Claim 7 (depends on 5)

The activity sensor of claim 5, further comprising a plurality of tuning domains wherein the tuning domains comprise ligands for receptors of a specific cell or a specific tissue type.

### Claim 8 (depends on 7)

The activity sensor of claim 7, wherein when the activity sensor is administered to a subject, the ligands promote accumulation of the activity sensor in the specific tissue type or body compartment, wherein the ligands each comprise one selected from the group consisting of a small molecule; a peptide; an antibody; a fragment of an antibody; a nucleic acid; and an aptamer.

### Claim 9 (depends on 5)

The activity sensor of claim 5, further comprising a plurality of tuning domains wherein the tuning domains comprise hydrophobic chains that facilitate diffusion of the activity sensor across a cell membrane.

### Claim 10 (depends on 5)

The activity sensor of claim 5, further comprising a plurality of reporters and a plurality of tuning domains, wherein the tuning domains comprise biocompatible polymer linked to the reporters.

### Claim 11 (depends on 10)

The activity sensor of claim 10, wherein the carrier comprises multiple subunits of covalently linked poly(ethylene glycol), wherein the reporters comprise peptide chains susceptible to cleavage by one or more enzymes, and the biocompatible polymers extend from the peptide chains and protect the activity sensor in vivo, thereby increasing a serum half-life of the activity sensor when administered to a subject relative to a activity sensor lacking the tuning domains.

### Claim 12 (depends on 10)

The activity sensor of claim 10, wherein:
the carrier comprises a bio-compatible scaffold;
the reporters comprise polypeptides susceptible to cleavage by one or more proteases; and
the tuning domains comprises polymers that shield the polypeptides from immune detection or inhibit cellular uptake of the activity sensor by macrophages.

### Claim 13 (depends on 12)

The activity sensor of claim 12, wherein the polypeptides comprise sequences susceptible to cleavage by proteases known to be associated with a specific disease and the tuning domain polymers comprise PEG side chains.

### Claim 14 (depends on 10)

The activity sensor of claim 10, wherein:
the carrier comprises a bio-compatible scaffold of about 30 to 40 kDa;
the reporters comprise polypeptides susceptible to cleavage by one or more proteases; and
the tuning domains comprises polymers between the scaffold and the polypeptides to decrease steric interference among parts of the activity sensor and thereby increase accessibility of the polypeptides to the proteases to promote successful cleavage.

### Claim 15 (depends on 10)

The activity sensor of claim 10, wherein: the carrier comprises a bio-compatible scaffold; the reporters comprise polypeptides susceptible to cleavage by one or more proteases; and the tuning domains comprise regions of the polypeptides comprising D-amino acids to prevent proteolytic cleavage of the regions.

### Claim 16 (depends on 15)

The activity sensor of claim 15, wherein the proteases are known to be expressed with a certain disease or medical condition, and further wherein delivery of the activity sensor to tissue of a subject affected by the disease or condition results in cleavage of the polypeptide and release of an analyte detectable in a sample from the subject, wherein the D-amino acids protect the analyte from digestion until detection.

### Claim 17 (depends on 15)

The activity sensor of claim 15, wherein a cleavage site of the polypeptides in tissue of a specific type is determined by a composition or relative order of the L- and D-amino acids in the polypeptides.

### Claim 18 (depends on 5)

The activity sensor of claim 5, wherein the reporter comprises a polypeptide that is cleaved from the activity sensor by proteases associated with a disease or physiological state and the tuning domain comprises one or more polymers on the polypeptide that facilitate passage of the reporter into systemic circulation after cleavage.

### Claim 19 (depends on 5)

The activity sensor of claim 5, wherein the reporter comprises a polypeptide that is liberated from the activity sensor by proteases associated with a disease or physiological state and the tuning domain comprises one or more polymers on the polypeptide that inhibit enzymatic activity upon the liberated reporter prior to excretion from the subject.

### Claim 20 (depends on 5)

The activity sensor of claim 5, wherein the tuning domain comprises a biocompatible polymer that protects the activity sensor from immune detection and clearance.

### Claim 21 (depends on 20)

The activity sensor of claim 20, wherein the reporter includes one selected from the group consisting of: a volatile organic compound; an elemental mass tag; a peptide comprising one or more D-amino acids; a nucleic acid; and a neoantigen.

### Claim 22 (depends on 21)

The activity sensor of claim 21, wherein the reporter comprises an elemental mass tag comprising an element of atomic number greater than 20.

### Claim 23 (depends on 21)

The activity sensor of claim 21, wherein the reporter comprises an antigen detectable by a hybridization assay.

### Claim 24 (depends on 5)

The activity sensor of claim 5, wherein the carrier comprises a bio-compatible scaffold and the reporter comprises at least one polypeptide susceptible to cleavage by a protease to release a detectable analyte, wherein the tuning domain forms a portion of the detectable analyte.
